A comprehensive review on recent advances in preparation, physicochemical characterization, and bioengineering applications of biopolymers

A Das, T Ringu, S Ghosh, N Pramanik - Polymer Bulletin, 2023 - Springer
Biopolymers are mainly the polymers which are created or obtained from living creatures
such as plants and bacteria rather than petroleum, which has traditionally been the source of …

Recent advances in nanotechnology-based diagnosis and treatments of human osteosarcoma

M Barani, M Mukhtar, A Rahdar, S Sargazi, S Pandey… - Biosensors, 2021 - mdpi.com
Osteosarcoma (OSA) is a type of bone cancer that begins in the cells that form bones. OSA
is a rare mesenchymal bone neoplasm derived from mesenchymal stem cells. Genome …

Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies

CM Hattinger, MP Patrizio, L Fantoni, C Casotti… - Cancers, 2021 - mdpi.com
Simple Summary Despite the adoption of aggressive, multimodal treatment schedules, the
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …

[HTML][HTML] Nanomaterial-assisted theranosis of bone diseases

K Zheng, J Bai, H Yang, Y Xu, G Pan, H Wang… - Bioactive Materials, 2023 - Elsevier
Bone-related diseases refer to a group of skeletal disorders that are characterized by bone
and cartilage destruction. Conventional approaches can regulate bone homeostasis to a …

[HTML][HTML] Advanced nanoscale drug delivery systems for bone cancer therapy

N Amiryaghoubi, M Fathi, J Barar, H Omidian… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Bone tumors are relatively rare, which are complex cancers and primarily involve the long
bones and pelvis. Bone cancer is mainly categorized into osteosarcoma (OS) …

Lignin-stabilized doxorubicin microemulsions: Synthesis, physical characterization, and in vitro assessments

A Rahdar, S Sargazi, M Barani, S Shahraki, F Sabir… - Polymers, 2021 - mdpi.com
Encapsulation of the chemotherapy agents within colloidal systems usually improves drug
efficiency and decreases its toxicity. In this study, lignin (LGN)(the second most abundant …

Hydroxyapatite biobased materials for treatment and diagnosis of cancer

MC De Lama-Odría, LJ Del Valle… - International journal of …, 2022 - mdpi.com
Great advances in cancer treatment have been undertaken in the last years as a
consequence of the development of new antitumoral drugs able to target cancer cells with …

Bio-evaluation of doxorubicin (DOX)-incorporated hydroxyapatite (HAp)-chitosan (CS) nanocomposite triggered on osteosarcoma cells

S Ghosh, S Ghosh, N Pramanik - Advanced Composites and Hybrid …, 2020 - Springer
A new strategic nanostructure consisting inorganic–organic combination for cancer
dominancy has been successfully developed using doxorubicin (DOX)-assimilated …

Calcium phosphate-based bioceramics in the treatment of osteosarcoma: Drug delivery composites and magnetic hyperthermia agents

TM Oliveira, FCB Berti, SC Gasoto… - Frontiers in Medical …, 2021 - frontiersin.org
The use of biomaterials in medicine is not recent, and in the last few decades, the research
and development of biocompatible materials had emerged. Hydroxyapatite (HAp), a calcium …

[HTML][HTML] DOX-loaded hydroxyapatite nanoclusters for colorectal cancer (CRC) chemotherapy: evaluation based on the cancer cells and organoids

T Deng, D Luo, R Zhang, R Zhao, Y Hu, Q Zhao… - SLAS technology, 2023 - Elsevier
It is meaningful to find suitable in vitro models for preclinical toxicology and efficacy
evaluation of nanodrugs and nanocarriers or drug screening and promoting clinical …